Spending on consumer drug advertising slows
The article notes a broad slowdown in brand drug ads while disease awareness campaigns grow. Regulators' scrutiny since 2004 and voluntary industry guidelines drive simpler, more candid ads with doctors describing products. FDA hearings hint at possible new rules, while trust in pharma ads remains low among consumers.
MENTIONED IN THIS ARTICLE
New York
Andrew Schirmer
Schirmer
Pfizer
McCann Humancare
Pharmaceutical
U.S. Food and Drug Administration
FDA
Gary Messplay
Messplay
Kaiser Family Foundation
Merck & Co
Dorothy Hamill
Frist backs two-year ban on drug ads in US health care
Senate leader Bill Frist urged a two-year moratorium on advertising new drugs, arguing commercials raise costs. A Harris Interactive survey for the Wall Street Journal Online found 35 percent of American adults support such a ban.
MENTIONED IN THIS ARTICLE
U.S. Senate
Bill Frist
Rtenn
Harris Interactive
Wall Street Journal Online
Oil prices rise on Nigeria unrest and Iran sanctions
Oil prices climbed as Nigeria unrest and Iran sanctions worries outweighed U.S. stock optimism. Light crude rose to 61.77 a barrel on the NYMEX, Brent gained to 62.20, gasoline and heating oil futures advanced, while analysts warned prices may drift despite strong fundamentals and high stockpiles.
MENTIONED IN THIS ARTICLE
London
Nigeria
U.N
Iran
U.S
New York Mercantile Exchange
Phil Flynn
Alaron Trading Corp
Chicago
ICE Futures Exchange
Brent
West
United States
Also Mentioned on This Page
TNS Media Intelligence
THE
Associated Press
Janice Graham
Odess Tak
Terican
al Sequin & Winter AO
University Market Place
Snelling
Penbrook
Ste
Permian
Basin
Workforce Development Board
N. A St. Bldg
Midland
Epetione
Janes
Kaye
Shier
Sylvan
N. Midkiff
Farning Yan Arning
Aood
Sbcglobal
Claiborne
N. Grandview Ave
Dunlaps.com